Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous conditioned serum for dry eye in Sjogren syndrome
IRCT20160422027520N16Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of autologous conditioned serum and artificial tears in dry eye syndrome (DED) and Sjögren's syndrome (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Tear film breakup time, Best corrected visual acuity and 3 more. Started Jan 2020; status: completed.
02
Drugs
autologous conditioned serumartificial tears
03
Conditions
dry eye syndrome (DED)Sjögren's syndrome
Beyond the preview
Go deeper on IRCT20160422027520N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160422027520N16.